In parallel experiments using the cultured primary PBMCs derived from the abovementioned 20 AML patients, we treated the cells with ATRA, followed by determination of RIG‐I expression, IFN signaling, and cell inhibition (Figure 3M). Here, RIGI is linked to acute myeloid leukemia.